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Abstract
Introduction: Cerebral microbleeds correspond to blood breakdown products, including hemosiderin-containing
macrophages around small vessels on histological examination. Superficial lobar cerebral microbleeds are
increasingly recognized on MRI as a biomarker of cerebral amyloid angiopathy but the direct association between
amyloid-laden vessels burden and cerebral microbleeds has yet to be validated neuropathologically. To address
this issue, we examined the frequency of histopathologically-defined cerebral microbleeds in different brain
regions and their relationship with cerebral amyloid angiopathy in a large autopsy population.
Results: The frontal, parietal and occipital cortex as well as the adjacent white matter and basal ganglia of 113
consecutive autopsies were examined. Cerebral microbleedss were identified on haematoxylin-eosin-stained
histological slides, cerebral amyloid angiopathy using anti-amyloid antibody. Cerebral microbleeds were present
in 92.9 % of the cases and cerebral amyloid angiopathy in 44.3 % of them. Cerebral microbleeds were more
frequent in parietal and frontal lobes followed by the occipital region and basal ganglia. In contrast, cerebral
amyloid angiopathy was most frequent in the occipital lobe. There was no significant topographical association
between cerebral amyloid angiopathy presence or severity and cerebral microbleeds in any brain region. In lobar
areas, cerebral amyloid angiopathy was found in the cortex, predominantly affecting pial arteries and their
superficial cortical branches, in contrast to microbleeds which were mainly in the white matter and occurred
around deeper arteries and arterioles, including the subcortical segment of long penetrating branches of pial
vessels.
Conclusions: Our study does not support a direct relation between cerebral microbleeds and cerebral amyloid
angiopathy burden at the neuropathological level, raising intriguing questions on the potential
pathophysiological mechanisms of cerebral microbleeds in the context of cerebral amyloid angiopathy or other
small vessel disease pathology.
Introduction
Cerebral microbleeds (CMB), an MRI marker of small
vessel disease in the brain, are increasingly recognized in
healthy elderly individuals and patients with Alzheimer’s
disease (AD) or cerebrovascular pathologies and vascular
cognitive impairement. Radiologically, CMB are defined as
small, rounded, hypointense lesions on blood-sensitive
MRI sequences, inlcuding T2*-weighed gradient echo
sequences and susceptibility-weighted imaging (SWI) [1,
2]. Limited neuropathological studies indicate that the ma-
jority of these radiologically-defined lesions correspond to
haemosiderin containing macrophages around small
vessels, mainly arterioles [3]. Despite the current hy-
pothesis of CMBs being a primarily haemorrhagic
marker of small vessel injury, the pathophysiological
mechanisms and histopathological basis of CMBs re-
main poorly understood and highly debated [4]. In fact,
recent neuropathological observations indicate hemo-
siderin within macrophages in the brain might not
always be indicative of CMB but rather being associated
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with iron clearance [5]. In addition, careful pathologic ana-
lysis in a population-based autopsy study has demonstrated
that a proportion of cerebral microbleeds are associated
with microinfarcts [6]. Hence, multiple mechanisms seem
likely to contribute to development of microbleeds [7].
Circumstantial evidence supports the hypothesis that
hypertensive arteriopathy is mainly associated with deep
CMB (i.e. in the basal ganglia, thalami etc.), whereas
cerebral amyloid angiopathy (CAA) is notably related to
superficial, lobar CMBs [3, 5, 8–15]. Since CAA path-
ology is not directly visible on neuroimaging, the in vivo
clinical diagnosis of CAA is currently based on the
recognition of multiple strictly lobar CMB on MRI, as a
putative marker of the disease [9, 16–19]. This approach
and more importantly the exact mechanism by which
CAA gives rise to CMB has not been explored in neuro-
pathological studies. Only a handful of cases have been
examined for histopathological confirmation of MRI data
[3, 12, 14, 20, 21]. Even fewer studies have examined the
direct neuropathological correlation between CAA and
lobar CMB [22].
Materials and methods
The study received approval from the Ethics Committee of
the University of Geneva. Brains were obtained by autopsies
from the Department of Internal Medicine, Rehabilitation
and Geriatrics, Division of Geriatrcs, and the Department
of Readaptation and Palliative Medicine, University
Hospitals, Geneva. We included 113 consecutive brain
autopsies – 33 cases with dementia - performed between
August 2012 to August 2014. For neuropathological ana-
lysis, tissues blocks were systematically taken in all cases
from the hippocampus, inferior temporal cortex (Brodmann
area 20), frontal cortex (Brodmann area 9), parietal cortex
(Brodmann area 40), occipital cortex (Brodmann areas 17
and 18) and the basal ganglia at the level of the anterior
commissure of the left cerebral hemisphere. Paraffin-
embedded 14-μm-thick adjacent sections were stained
with haematoxylin-eosin (HE), cresyl-violet (Nissl) and
using anti-Aβ monoclonal antibodies (4G8; Signet
Laboratories, Dedham, MA, USA; 1:2000) and anti-tau
(AT8; Pierce Biotechnology, Rockford, IL, USA; 1:1000)
consecutively. The severity of AD-related neuropathological
changes was defined using the Braak stages for neurofibril-
lary tangles (NFTs) and the Thal phases for amyloid plaque
deposition [23, 24] in the medial temporal lobe.
The presence or absence of CMB was noted on HE-
stained histological sections. A case was considered positive
for CMBs when haemosiderin-laden macrophages were
present around at least one vessel, in one or more of the
sampled regions. The presence or absence of CAA was de-
termined on anti-Aβ-antibody-stained sections. In the basal
ganglia only grey matter lesions but no lesions in the sur-
rounding white matter or internal capsule were taken into
consideration.
On a four-level grading system CAA severity and burden
was evaluated based on the existing systems of Vonsattel
and al. [25] and Olichney et al. [26]. The average severity of
amyloid deposition in the vessels wall and the extent of the
lesions were taken in account as follows: grade 0 was noted
in the absence of CAA. In grade 1 only a thin amyloid-
positive rim was observed around smooth muscle cells
of the otherwise normal media layer of scattered vessels
(Fig. 1a, d). Grade 2 showed more extensive depositions
Fig. 1 Grading of the severity of amyloid angiopathy. Grade 1: scattered amyloid deposition presenting as a thin rim of Aβ positive fibers around
the smooth muscle cell of the media (a and d); Grade 2: more extensive presence of amyloid in the vessel’s wall with focal replacement of the
muscular layer (b and e); Grade 3: complete destruction of the wall by the severe amyloid deposition, present in most pial and superficial vessels
(c and f). The absence of amyloid, grade 0 not shown in the figure. (4G8 anti amyloid antibody (a-f). Scale bars:a,b and c: 500 μm; d, e and
f: 50 μm)
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and the medial layer of the vessels replaced by amyloid
(Fig. 1b, e). Grade 3 was characterized by circumferential,
severe destruction of the wall by amyloid deposition, with
most vessels being affected (Fig. 1c, f). Separately, in each
case the exact localisation (meningeal or meningo-cortical)
as well as the presence and severity of capillary amyloid de-
position [27] was noted as recently proposed by Love et al.
[28]. The severity of capillary amyloid deposition was
defined on ground of its extension.
Statistical analysis
Group comparisons were performed using Fisher’s exact
test for dichotomous variables, Student t-test for con-
tinuous variables or Wilcoxon–Mann–Whitney u-test
for ordinal variables as appropriate. Multivariable logistic
regression analyses were used to evaluate the association
between the dependent variables (CMB or CAA) within
each brain area and the independent variables (Braak NFT
staging, Aβ deposition staging) with and without adjust-
ment for age. Significance level was set at 0.05 and all tests
of significance were two-tailed. All statistical analyses were
carried out using Stata version 13.1 (Stata Corporation,
College Station, TX, USA).
Results
Our study sample consisted of 64 women and 49 men
(mean age: 81.1 ± 10.8 years; age range: 51 – 99 years;
Table 1). Macroscopic intracerebral haemorrhage was
found only in two cases, both in subtentorial regions
(brainstem and cerebellum). Lobar CMB were found in
92.9 % of the study population whereas CAA was
present in 44.3 % of the cases. In the different diagnos-
tic groups distinct prevalences of CAA was observed,
the highest in the 25 cases with AD (Braak stage ≥ 4; 14
pure AD and 11 associated with vascular encephalop-
athy – Table 2). The prevalence of CMBs was highest in
the parietal (84.1 %) and frontal lobes (76.9 %), followed
by the occipital area (46.9 %). In contrast, CAA was more
frequent in the occipital lobe (38.9 %), compared to frontal
(30.9 %) and parietal areas (28.3 %). Parenchymal (cortical)
CAA was most frequent in the occipital area, in 72.3 % of
CAA cases (Table 3).
Basal ganglia CMBs were identified in 46.2 % of the
cases. CAA in the basal ganglia was seen in 1 case only.
With the exception of 3 cases, basal ganglia CMBs were
accompagnied by lobar CMBs in at least one cortical
area.
Capillary amyloid deposition was observed in 12 sub-
jects (24 % of CAA positive cases and 10 % of the total
population). Seven cases showed moderate-severe, 5 mild
amyloid deposition. Capillary amyloid deposition (type 1)
[27] or its severity did not influence the presence or
absence of CMB (frontal lobe: p =0.209; parietal lobe:
p =0.379; occipital lobe: p =0.736).
There was no significant association between the
presence of CAA and lobar CMB either overall (Fisher’s
exact p =0.463) or separately in each brain region exam-
ined. CAA, was associated with age (p < 0.001) but CMB
were not. CAA in the white matter was rare (5 cases,
4.4 %) and only 8 cases (7 %) exhibited intracortical CMBs,
indicating that these lesions occur in different compart-
ments of the brain (Fig. 2). On close topographical ana-
lysis, CAA and CMB involved different types or different
segments of vessels. CAA was mainly present in the pial
arteries and their superficial short perforating branches,
and less often in the superficial (intra-cortical) segments
of long branches, e.g. in the surface of the brain or in the
superficial cortical layers. In contrast, lobar microbleeds
were detected in the adjacent white matter, often at the
cortical-white matter junction (i.e. juxtacortical at the level
of and around the long branches of pial vessels and
the medullary arteries) or around deeper arteries and
arterioles (Fig. 3).
We explored whether CMB presence in the underlying
juxtacortical white matter was related to leptomeningeal/
cortical CAA. We found no association in any of the
studied regions for either the presence (Fisher’s exact test
p = 0.628; 0.776; and 0.701) or severity (Mann–Whitney
Table 1 Demographic data
Number of cases Mean age ± SD
Total (M/F) 113 (49/64) 81.1 ± 10.8
Non demented 80 79.1 ± 11.7
Dementia 33 85.7 ± 6.4
AD 14 84.8 ± 7.1
VaD 5 88.2 ± 3.6
Mixed D 11 86.2 ± 7.1
LBD 3 84.3 ± 6.1
AD Alzheimer’s disease, VaD vascular dementia, Mixed D mixed (AD and
vascular) dementia, LBD Lewy body dementia
Table 2 Frequencies of CAA and CMB and mean CAA severities












AD 14 71 78 1.5
Va 29 55 93 1.2
AD + Va 11 63 91 1.7
C 34 38 91 0.7
Others 25 16 100 0.5
AD Alzheimer’s disease, Va vascular encephalopathy, AD + Va mixed (AD-type
and vascular encephalopathy), C no brain lesions, Others = any type of Lewy
body pathology as Parkinson’s disease, Lewy body dementia – 8 cases, or
multiple system atrophy (1 case), amyotrophic lateral sclerosis (2 cases) or
brain metastases (14 cases)
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p =0.326; 0.656; 0.628) of leptomeningeal/cortical CAA in
frontal, parietal and occipital lobes, respectively.
Discussion
Our report is the first systematic neuropathological study
in a large autopsy series directly examining the relation-
ship between CMB and CAA, including their anatomical
distribution. According to our primary findings there is no
association between the overall presence and burden of
CAA and histopathologically-defined CMB presence, nor
Table 3 Distribution of CAA and the proportion of meningeal






mx_CAA (%) mx_cx_CAA (%)
Frontal (35) 30.9 18 (51.4) 17 (48.6)
Parietal (32) 28.3 13 (40.6) 19 (59.4)
Occipital (44) 38.9 12 (27.3) 32 (72.3)
Mx_CAA CAA present only in meningeal vessels, mx_cx_CAA CAA present in
both meningeal and cortical vessels
Fig. 2 Percentage of cases with CMB and CAA. Distribution of CAA and CMB in the cortex and subcortical white matter. Note that CMB and CAA
occur in different sectors of the brain (see text for details)
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concerning their topography within brains. These results
raise interesting questions about the precise mechanisms
underlying the development of most microbleeds.
We report a high frequency of CAA which is in line
with earlier results from our group [29] and other pub-
lished data from consecutive autopsy cases that used im-
munohistochemical detection methods [30, 31]. CMBs
were more frequently detected in the current cohort com-
pared to other autopsy based studies. This may be related
in part to strict adherence to the neuropathological defin-
ition and, close attention to the presence of CMBs since
their identification was a main aim of the study. Fisher et
al. reported a CMB prevalence of 66 % in 33 autopsy cases
[32]. In a large population-based autopsy study of older
people with intracerebral hemorrhage (n = 300), Tanskanen
et al. investigated the presence and extent of CMBs [6] and
found them in 67.3 % of the cases. This confirms that
neuropathological-defined CMB on histologic examination
are much more common compared to rediologically-
defined CMBs.
Our results do not confirm a direct neuropathological
relationship between lobar CMB and CAA. This is con-
sistent with a recent study of cerebellar microbleeds by de
Reuck et al. who reported that CMB were related to ath-
erosclerosis but not to CAA [33]. This contrasts with the
bulk of the neuroimaging-based literature [15, 34–37]. In
the population-based Rotterdam scan study [15] there was
a strong association between strictly lobar (but not deep)
CMBs and APOE ε4 (later confirmed in a meta-analysis
[38]), consistent with the well-known relation of this allele
with CAA [1]. The APOE ε2 allele is also of major import-
ance in CAA-related cerebral hemorrhage [39], although
its exact role in CMBs mechanisms is still unexplored in
the literature. In another healthy elderly cohort, multiple
lobar CMBs were recently found to be associated with
higher amyloid-β burden, as detected by 11C-Pittsburgh
Compound B positron emission tomography (PiB-PET)
imaging [40]. Co-registered PiB-PET imaging has shown
that lobar CMB hotspots preferentially correspond to lo-
cations with increased amyloid concentration [41]. How-
ever, PiB-PET has poor spatial resolution and, similar to
the other clinical-radiological studies on the topic, cannot
reliably resolve the location of parenchymal and vascular
amyloid-β. Thus, histopathological validation and studies
on the pathogenesis of CMB at the level of individual ves-
sel pathology are crucial to supplement imaging studies.
One of our main results is the spatial dissociation be-
tween CMB and CAA that was observed on close neuro-
pathological examination. CAA predominantly affected pial
arteries, and their superficial cortical branches; in contrast,
CMB were found at the level of white matter cortical per-
forating vessels or medullary arteries. This is consistent
with a study of 8 AD patients by Schrag and colleagues [12]
who reported that the majority of pathologically-defined
CMB occurred near the cortical ribbon in the adjacent
white matter. In a larger autopsy series, Tanskanen et al. [6]
mentioned that even in the simultaneous presence of CMB
and CAA on the same histological slide, CMBs were not al-
ways situated around amyloid-laden vessels. Fisher et al.
[32] in their series of 33 cases also report the occurrence of
CMB around vessels without any evidence of amyloid de-
position. The neuropathological studies that report a direct
relationship between CAA and CMB are scarce and based
on a very small number of subjects [12, 21]. In a series of 6
autopsy cases with CAA that included 3 cases with high
CMB counts, 2 cases with a low number of CMB and 1 case
without any microbleed, Greenberg and collaborators ob-
served a thicker amyloid positive vessel wall in subjects with
Fig. 3 Topographical distribution of CMB and CAA. a Normal microvascular architecture of the cerebral cortex and underlying white matter. b
Hemosiderin-laden macrophages (arrowheads) around small arteries of the white matter. c Amyloid angiopathy (arrowheads) in the pial and
superficial cortical branches. a: modified Gallyas silver-impregnation; b: haematoxylin-eosin staining; c: immunohistochemistry with anti-amyloid
antibody 4G8. Scale bar on A: 500 μm)
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numerous microbleeds [21]. Schrag et al. [12] performed
postmortem MRI in 8 AD autopsy cases and found ad-
vanced CAA in 6 of them, with amyloid deposion in the
vessel’s wall near microbleeds.
Our study has several limitations which should taken into
account. It was peformed in a hospital based autopsy series
with a high mean age, and may represent a more severely
affected population than community based samples, where
the frequency of CMB might be lower. Also, we report on
the presence or absence of CMB,including very small le-
sions, clearly identifiable on neuropathological examination
but probably very hard to visualize on conventional MRI.
Finally, we have analyzed the relation between lobar CMB
and CAA pathology, regardless of the concurrent presence
in the same brain of CMB in deep gray matter or
brainstem CMB, which might indicate the presence and
contribution of non-CAA small vessels disease
pathology in the pathophysiology of microbleeds.
Conclusions
Our study does not intend to underemphasise the clinical
importance of the in vivo detection of MRI-defined CMB or
critically analyze the current MRI Boston diagnostic criteria,
since it does not contain either MRI or clinical data. How-
ever, our neuropathological data provide evidence that the
assumed link between CAA and lobar CMB, an MRI de-
rived concept, does not seem to have a clear direct neuro-
pathological validity, at least at the level of individual vessel
pathology. Of note, there seems to be a dissconnection of
the MRI-definition vs. pathological definition of CMBs. For
example, CMBs detected on 3 T blood-sensitive sequences
are likely mostly very much larger than the few hemosiderin
deposits that are observed microscopically. The literature
on CMBs overwhelmingly emphasizes them as a haemor-
rhagic signature and stress the hemorrhagic risk associated
with microbleeds. However, some authors have postulated
that parenchymal iron deposits may arise both from
haemorrhagic and ischaemic mechanisms. Therefore the
field is using the same terminology to describe what may
be different types of lesion - a more definitive radio-
graphic imaging marker, with as-yet uncertain pathologic
basis [7]. Further studies will need to explore additional
potential pathophysiological mechanisms that could lead
to the occurrence of CMB, including direct imaging-
pathologic correlation studies and ex-vivo MRI data.
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